Matthew Winton's Ownership Filing for CervoMed Inc.
2025-10-08SEC Filing 3 (0001437749-25-030705)
Matthew Winton, Chief Commercial and Business Officer of CervoMed Inc., filed a Form 3 with the SEC on October 7, 2025, reporting no securities owned as of October 6, 2025. The filing indicates his position and relationship with the company, along with his address in Boston, MA. This form is a standard disclosure for officers and directors to report their ownership in the company.
Tickers mentioned in this filing:CRVO
The link to the original SEC document:https://www.sec.gov/Archives/edgar/data/1053691/0001437749-25-030705.txt